r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

BH

Beth Hecht

Insider · Officer · XERS

Beth Hecht files insider transactions with the SEC as an officer of Xeris Biopharma Holdings (XERS). We hold 9 disclosed purchases and sales filed since 1 October 2015, 3 of them in the last 90 days.

  • Files forXERS
  • Disclosed buys and sells9 in all, 3 in the last 90 days
  • Last disclosure1 September 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 31 January 2019 — 1 September 2026Officer · Xeris Biopharma Holdings (XERS)67 Form 4 lines · source: SEC Form 4
  • Filed 18 March 2021 — 15 June 2023Director · Iterum Therapeutics (ITRM)9 Form 4 lines · source: SEC Form 4
  • Filed 8 April 2021 — 8 April 2021Director · Aytu Biopharma (AYTU)1 Form 4 line · source: SEC Form 4
  • Filed 1 October 2015 — 19 March 2021Director · Neos Therapeutics (NEOS)12 Form 4 lines · source: SEC Form 4

Everything they disclosed

89 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.